Unlock stock picks and a broker-level newsfeed that powers Wall Street.
VirTra Inc (VTSI) Q4 2024 Earnings Call Highlights: Navigating Challenges with Strategic Growth ...

In This Article:

  • Q4 Revenue: $5.4 million, down from $10.9 million in the prior year period.

  • Full Year 2024 Revenue: $26.4 million, compared to $38.8 million in 2023.

  • Q4 Bookings: $12.2 million, a 37% sequential increase from Q3 2024.

  • Full Year 2024 Bookings: $29.6 million, a decline of $4.2 million year-over-year.

  • Q4 Gross Profit: $3.7 million or 69% of total revenue.

  • Full Year 2024 Gross Profit: $19.4 million or 74% of total revenue.

  • Q4 Net Operating Expense: $4.2 million, a 13% increase from the prior year period.

  • Full Year 2024 Net Operating Expense: $17.4 million, compared to $17 million in 2023.

  • Q4 Net Loss: $0.9 million or negative $0.08 per diluted share.

  • Full Year 2024 Net Income: $1.4 million or $0.12 per diluted share.

  • Full Year 2024 Adjusted EBITDA: $2.9 million, compared to $12.4 million in 2023.

  • Cash and Cash Equivalents: $18 million as of December 31, 2024.

  • Backlog as of December 31, 2024: $22 million.

Release Date: March 27, 2025

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

  • VirTra Inc (NASDAQ:VTSI) achieved sequential bookings growth in every quarter of 2024, indicating a strong recovery in demand and sales execution.

  • The company closed the year with a $22 million backlog, positioning it well for revenue conversion as market conditions stabilize.

  • VirTra Inc (NASDAQ:VTSI) secured international contracts, expanding its presence in Europe and Latin America, and recorded its first V-XR platform sale in Canada.

  • The company has significantly expanded its scenario catalog and leveraged AI efficiencies to accelerate content production, enhancing its leadership in immersive training.

  • VirTra Inc (NASDAQ:VTSI) completed the final development phase for the US Army's Integrated Visual Augmentation System (IVAS) program ahead of schedule, marking a significant milestone.

Negative Points

  • Total revenue for the fourth quarter was $5.4 million, a significant decrease from $10.9 million in the prior year period, due to federal budget delays and grant distribution pauses.

  • For the full year 2024, revenue was $26.4 million compared to $38.8 million in 2023, reflecting a challenging funding environment.

  • Net operating expense for the fourth quarter increased by 13% from the prior year period, driven by investments in personnel and expanded sales and marketing efforts.

  • The company reported a net loss of $0.9 million for the fourth quarter, compared to net income of $3.5 million in the same period of 2023.

  • Federal grant disbursement delays have impacted near-term order conversion timing, creating uncertainty in revenue recognition.